PRF Technologies (PRFX) Debt Ratio (2019 - 2020)
PRF Technologies' (PRFX) quarterly Debt Ratio came in at 6.42 in Q2 2020, up 50.66% on a QoQ basis from 4.26 in Q4 2019.
PRF Technologies (PRFX) Debt Ratio (2019 - 2020) Analysis & Trends
PRF Technologies (PRFX) has 2 years of Debt Ratio data on file, last reported at 6.42 in Q2 2020.
- Quarterly Debt Ratio changed N/A year-over-year to 6.42 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was 6.42 (changed N/A YoY) and the FY2019 annual result came in at 4.26, changed N/A from the prior year.
- Debt Ratio climbed to 6.42 in Q2 2020, from 4.26 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 6.42 in Q2 2020 to a low of 4.26 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 43.60 Bn | 39.95 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 32.45 Bn | 30.77 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.99 Bn | 18.10 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 0.12 |
| 10 | PRF Technologies | 640,715.70 | -3.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 6.42 |
| Dec 31, 2019 | 4.26 |